Aufman Associates Inc Neogenomics Inc Call Options Transaction History
Aufman Associates Inc
- $141 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NEO
# of Institutions
277Shares Held
127MCall Options Held
581KPut Options Held
115K-
Black Rock Inc. New York, NY19.7MShares$275 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$198 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$123 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$94.2 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$92.7 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.76B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...